Global /Germany /Healthcare /Biotechnology /7V0

Darwin AG

7V0

• XETRA: 7V0 • Delayed

8.70EUR 0%

10.02 USD

As of 6 June 2026, Darwin AG has a market cap of $107.32M USD, ranking #25030 globally and #271 in Germany. It ranks #2242 in the Healthcare sector, and #429 in the Biotechnology industry.

Global Rank

25030

Country Rank

271

Sector Rank

2242

Industry Rank

429

Key Stats

Market Cap

$107.32MUSD

92.4M EUR

Enterprise Value

$52.46MUSD

45.53M EUR

Revenue (TTM)

$31.77MUSD

27.35M EUR

EBITDA (TTM)

$33.57MUSD

29.14M EUR

Net Income (TTM)

$21.44MUSD

18.46M EUR

EBITDA Margin

107%

Profit Margin

67%

PE Ratio

5.0

Forward PE

72.6

PS Ratio

3.4

PB Ratio

0.9

EV/EBITDA

1.6

Company Profile

Country (HQ)

Germany

Sector

Healthcare

Industry

Biotechnology

CEO

Daniel Wallerstorfer open_in_new

Employees

177

Founded

2021

Website

darwin-biotech.com open_in_new

warningChart data may be delayed

1d	1w	1m	3m	6m	YTD	1y	3y	5y
0%	12%	4.8%	-16%	14%	13%	27%	-36%	-36%

News

Markets

Exchange	Ticker	Price	Quotes
Deutsche Börse Xetra (XETRA) MIC: XETR PRIMARY	7V0 ISIN: DE000A3C35W0 Shares Out.: Shares Outstanding: 12.0M¹ Shares Float: 9.001M² TV: TradingView: XETR: 7V0 SA: Stock Analysis: ETR: 7V0 YF: Yahoo Finance: 7V0.DE GF: Google Finance: FRA: 7V0 BA: Barron's: 7V0 MS: Morningstar: XETR: 7V0	8.70 EUR	TV: TradingView: XETR: 7V0 SA: Stock Analysis: ETR: 7V0 YF: Yahoo Finance: 7V0.DE GF: Google Finance: FRA: 7V0 BA: Barron's: 7V0 MS: Morningstar: XETR: 7V0
Frankfurt Stock Exchange (FRA) MIC: XFRA	7V0 ISIN: DE000A3C35W0 TV: TradingView: FWB: 7V0 SA: Stock Analysis: FRA: 7V0 YF: Yahoo Finance: 7V0.F GF: Google Finance: FRA: 7V0 BA: Barron's: 7V0 MS: Morningstar: XFRA: 7V0	8.70 EUR	TV: TradingView: FWB: 7V0 SA: Stock Analysis: FRA: 7V0 YF: Yahoo Finance: 7V0.F GF: Google Finance: FRA: 7V0 BA: Barron's: 7V0 MS: Morningstar: XFRA: 7V0

¹Market cap is calculated using shares outstanding.

²Float shares are publicly tradable shares, excluding insider-held stock.

About Darwin AG

Darwin AG operates in the healthcare industry. The company offers dietary supplements and cosmetics products. It also provides consulting and support services. The company was incorporated in 2021 and is based in Munich, Germany.

Similar Companies

Industry: Biotechnology (Germany)

Name	Market Cap (USD) diff.	PE	Country
BioNTech SE NASDAQ: BNTX	$25.69B 24K%	-	Germany
Biotest Aktiengesellschaft XETRA: BIO	$1.69B 1.46B EUR 1K%	-	Germany
CureVac N.V. NASDAQ: CVAC	$1.04B 869%	5.0	Germany
InflaRx N.V. NASDAQ: IFRX	$143.14M 33%	-	Germany
FamiCord AG XETRA: V3V	$89.49M 77.05M EUR -17%	-	Germany
BRAIN Biotech AG XETRA: BNN	$67.75M 58.33M EUR -37%	-	Germany

Industry: Biotechnology (Global)

Name	Market Cap (USD) diff.	PE	Country
Amgen Inc. NASDAQ: AMGN	$182.42B 170K%	23.9	United States
Gilead Sciences, Inc. NASDAQ: GILD	$159.92B 149K%	19.0	United States
argenx SE EBR: ARGX	$48.08B 41.39B EUR 45K%	39.9	Netherlands
Samsung Biologics Co.,Ltd. KRX: 207940	$44.48B 68.19T KRW 41K%	35.5	South Korea
CSL Ltd. ASX: CSL	$43.01B 60.27B AUD 40K%	29.3	Australia
Lonza Group AG SIX: LONN	$42.72B 33.71B CHF 40K%	37.2	Switzerland

chevron_leftBack